However, the way science works, not by straight lines, but sometimes by accident, can frustrate strict timelines and investment efforts.
As the world tackles the challenge of overcoming Coronavirus, scientific research has once again entered center stage. This attention has brought opportunities for innovation. But our age of content overload and expectation of “quick fixes’ has also brought new mountains to climb for those seeking investment in science and technology.
Why is continued scientific investment so important? Can science overcome many of the challenges it faces today in order to lead us to a brighter future? How can we encourage diversity and inclusion in the field to ensure the best and brightest scientific workforce?
The Hill will bring policy-makers and thought leaders together to look at the historical contributions science has made to American advancement and the status of the scientific community today.
Â
Phyllis Arthur, Vice President, Infectious Diseases and Diagnostics Policy, BIO
Holden Thorp, Editor-in-Chief, Science MagazineÂ
Dr. Vaughan C. Turekian, Executive Director of Policy and Global Affairs at the National Academies of Sciences, Engineering, and Medicine
Benjamin Corb, Director, Public Affairs, American Society for Biochemistry and Molecular Biology